应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BMEA Biomea Fusion, Inc.
未开盘 07-19 16:00:00 EDT
5.04
-0.12
-2.33%
盘后
5.04
+0.00
0.00%
18:41 EDT
最高
5.23
最低
5.00
成交量
23.29万
今开
5.17
昨收
5.16
日振幅
4.46%
总市值
1.81亿
流通市值
9,803万
总股本
3,594万
成交额
118.38万
换手率
1.20%
流通股本
1,945万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Biomea Fusion, Inc.盘中异动 股价大跌5.08%
自选股智能写手 · 07-19
Biomea Fusion, Inc.盘中异动 股价大跌5.08%
Biomea Fusion, Inc.盘中异动 急速下跌5.00%报5.32美元
自选股智能写手 · 07-17
Biomea Fusion, Inc.盘中异动 急速下跌5.00%报5.32美元
Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.04%
自选股智能写手 · 07-17
Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.04%
Biomea Fusion, Inc.盘中异动 早盘急速上涨5.24%
自选股智能写手 · 07-12
Biomea Fusion, Inc.盘中异动 早盘急速上涨5.24%
Biomea Fusion, Inc.盘中异动 股价大涨5.05%报4.99美元
自选股智能写手 · 07-11
Biomea Fusion, Inc.盘中异动 股价大涨5.05%报4.99美元
Biomea Fusion, Inc.盘中异动 早盘股价大涨5.67%报4.47美元
自选股智能写手 · 07-08
Biomea Fusion, Inc.盘中异动 早盘股价大涨5.67%报4.47美元
Biomea Fusion, Inc.盘中异动 早盘股价大涨5.20%
自选股智能写手 · 07-02
Biomea Fusion, Inc.盘中异动 早盘股价大涨5.20%
Biomea Fusion, Inc.盘中异动 早盘快速拉升5.11%报4.73美元
自选股智能写手 · 07-01
Biomea Fusion, Inc.盘中异动 早盘快速拉升5.11%报4.73美元
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.36%
自选股智能写手 · 06-26
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.36%
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.05%报5.27美元
自选股智能写手 · 06-25
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.05%报5.27美元
Biomea Fusion, Inc.盘中异动 股价大涨5.51%
自选股智能写手 · 06-24
Biomea Fusion, Inc.盘中异动 股价大涨5.51%
Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.15%报5.10美元
自选股智能写手 · 06-21
Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.15%报5.10美元
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.30%报4.82美元
自选股智能写手 · 06-18
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.30%报4.82美元
Biomea Fusion, Inc.盘中异动 股价大跌5.39%报5.34美元
自选股智能写手 · 06-17
Biomea Fusion, Inc.盘中异动 股价大跌5.39%报5.34美元
Biomea Fusion, Inc.盘中异动 早盘大幅上涨5.19%报4.66美元
自选股智能写手 · 06-12
Biomea Fusion, Inc.盘中异动 早盘大幅上涨5.19%报4.66美元
BUZZ-Truist 将 Biomea Fusion 的评级下调至 "持有"。
Reuters · 06-11
BUZZ-Truist 将 Biomea Fusion 的评级下调至 "持有"。
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.07%报3.93美元
自选股智能写手 · 06-10
Biomea Fusion, Inc.盘中异动 早盘股价大跌5.07%报3.93美元
BUZZ-美国食品及药物管理局暂停糖尿病药物临床试验,Biomea 公司业绩下滑
Reuters · 06-07
BUZZ-美国食品及药物管理局暂停糖尿病药物临床试验,Biomea 公司业绩下滑
BUZZ-美国 FDA 暂停糖尿病试验,Biomea 业绩下滑
Reuters · 06-07
BUZZ-美国 FDA 暂停糖尿病试验,Biomea 业绩下滑
美国 FDA 暂停 Biomea 的糖尿病试验
Reuters · 06-07
美国 FDA 暂停 Biomea 的糖尿病试验
公司概况
公司名称:
Biomea Fusion, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Biomea Fusion, Inc.于2017年8月9日根据特拉华州法律注册成立。他们是一家临床前阶段的生物制药公司,致力于发现,开发和商品化不可逆小分子药物,以治疗患有遗传性癌症的患者。
发行价格:
--
{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":5.04,"timestamp":1721419200000,"preClose":5.16,"halted":0,"volume":232911,"hourTrading":{"tag":"盘后","latestPrice":5.04,"preClose":5.04,"latestTime":"18:41 EDT","volume":7789,"amount":39256.56,"timestamp":1721428897917},"delay":0,"floatShares":19450495,"shares":35944584,"eps":-3.566554,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.12,"latestTime":"07-19 16:00:00 EDT","open":5.17,"high":5.23,"low":5,"amount":1183776.1433126999,"amplitude":0.044574,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.566554,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":0,"listingDate":1618545600000,"adjPreClose":5.16,"preHourTrading":{"tag":"盘前","latestPrice":5.32,"preClose":5.16,"latestTime":"08:33 EDT","volume":52,"amount":273.0400192,"timestamp":1721392431009},"postHourTrading":{"tag":"盘后","latestPrice":5.04,"preClose":5.04,"latestTime":"18:41 EDT","volume":7789,"amount":39256.56,"timestamp":1721428897917},"volumeRatio":0.37382309075119446,"impliedVol":1.1829,"impliedVolPercentile":0.548},"requestUrl":"/m/hq/s/BMEA/wiki","defaultTab":"wiki","newsList":[{"id":"2452439714","title":"Biomea Fusion, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439714","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452439714?lang=zh_cn&edition=full","pubTime":"2024-07-19 00:05","pubTimestamp":1721318719,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日00时05分,Biomea Fusion, Inc.股票出现异动,股价急速下跌5.08%。截至发稿,该股报5.05美元/股,成交量22.4275万股,换手率0.62%,振幅6.95%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为2.27%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大,Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为2272.15%、2205.20%、1188.44%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719000520af9300b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719000520af9300b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4539","BK4139","BK4585"],"gpt_icon":0},{"id":"2452936166","title":"Biomea Fusion, Inc.盘中异动 急速下跌5.00%报5.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452936166","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452936166?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:07","pubTimestamp":1721228873,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时07分,Biomea Fusion, Inc.股票出现异动,股价快速下挫5.00%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为2.56%。其相关个股中,Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Moolec Science Sa C/Wts 涨幅较大,Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃,换手率分别为2877.99%、1291.00%、269.80%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为76.39%、46.25%、43.75%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172307539681db20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172307539681db20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4539","BMEA"],"gpt_icon":0},{"id":"2452094953","title":"Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452094953","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452094953?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:34","pubTimestamp":1721154862,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时34分,Biomea Fusion, Inc.股票出现异动,股价快速拉升5.04%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,Silo Pharma, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3901.80%、1325.02%、421.42%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为79.41%、70.56%、68.00%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023423941f7825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023423941f7825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4539","BK4585","BK4139"],"gpt_icon":0},{"id":"2450535303","title":"Biomea Fusion, Inc.盘中异动 早盘急速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535303","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450535303?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:32","pubTimestamp":1720791137,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时32分,Biomea Fusion, Inc.股票出现异动,股价急速拉升5.24%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Zura Bio Limited C/Wts 、Qualigen Therapeutics, Inc.、Instil Bio, Inc.涨幅较大,Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为644.64%、74.16%、23.35%,振幅较大的相关个股有Zura Bio Limited C/Wts 、Anew Medical Inc C/Wts 21/06/2029 、Qualigen Therapeutics, Inc.,振幅分别为20.00%、13.95%、11.64%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213217aef97a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213217aef97a51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BMEA","BK4139"],"gpt_icon":0},{"id":"2450363450","title":"Biomea Fusion, Inc.盘中异动 股价大涨5.05%报4.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450363450","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450363450?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:35","pubTimestamp":1720704915,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时35分,Biomea Fusion, Inc.股票出现异动,股价急速拉升5.05%。截至发稿,该股报4.99美元/股,成交量3.0295万股,换手率0.08%,振幅3.37%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为265.08%、195.60%、177.18%,振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Lexeo Therapeutics, Inc.,振幅分别为31.43%、22.94%、15.15%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213516aef93d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213516aef93d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BMEA","BK4539"],"gpt_icon":0},{"id":"2449706718","title":"Biomea Fusion, Inc.盘中异动 早盘股价大涨5.67%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449706718","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449706718?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:05","pubTimestamp":1720447542,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时05分,Biomea Fusion, Inc.股票出现异动,股价急速拉升5.67%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Virpax Pharmaceuticals, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃,换手率分别为848.81%、162.79%、134.20%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为65.74%、36.60%、34.48%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708220543af911788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708220543af911788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4539","BMEA"],"gpt_icon":0},{"id":"2448416530","title":"Biomea Fusion, Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448416530","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448416530?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:08","pubTimestamp":1719932889,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日23时08分,Biomea Fusion, Inc.股票出现波动,股价大幅上涨5.20%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为0.78%。其相关个股中,Zura Bio Limited C/Wts 、Nls Pharmaceutics Ltd.、Mustang Bio, Inc.涨幅较大,Mustang Bio, Inc.、Gri Bio, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为47.37%、45.50%、35.30%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Anew Medical Inc C/Wts 21/06/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为72.83%、39.76%、39.50%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702230809941f3285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702230809941f3285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4585","BK4539","BK4139"],"gpt_icon":0},{"id":"2448919679","title":"Biomea Fusion, Inc.盘中异动 早盘快速拉升5.11%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448919679","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448919679?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:33","pubTimestamp":1719844428,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时33分,Biomea Fusion, Inc.股票出现波动,股价快速拉升5.11%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为429.24%、127.96%、97.36%,振幅较大的相关个股有Senti Biosciences, Inc.、Seastar Medical Holding Corporation、Humacyte Inc C/Wts 27/08/2026 ,振幅分别为101.49%、31.27%、28.78%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701223348af9009f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701223348af9009f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4539","BMEA"],"gpt_icon":0},{"id":"2446968193","title":"Biomea Fusion, Inc.盘中异动 早盘股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446968193","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446968193?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:35","pubTimestamp":1719408925,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时35分,Biomea Fusion, Inc.股票出现异动,股价大幅下挫5.36%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Neurobo Pharmaceuticals, Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为326.08%、68.36%、65.47%,振幅较大的相关个股有Anew Medical, Inc.、Io Biotech, Inc.、Atossa Therapeutics, Inc.,振幅分别为40.61%、25.20%、20.87%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213525af8f5768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213525af8f5768&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BMEA","BK4139"],"gpt_icon":0},{"id":"2446379844","title":"Biomea Fusion, Inc.盘中异动 早盘股价大跌5.05%报5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446379844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446379844?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:52","pubTimestamp":1719323548,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时52分,Biomea Fusion, Inc.股票出现异动,股价大幅下跌5.05%。截至发稿,该股报5.27美元/股,成交量7.8843万股,换手率0.22%,振幅5.41%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为1.36%。其相关个股中,Glycomimetics, Inc.、Senti Biosciences, Inc.、Effector Therapeutics, Inc.涨幅较大,Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为121.92%、116.19%、75.80%,振幅较大的相关个股有Werewolf Therapeutics, Inc.、Senti Biosciences, Inc.、Glycomimetics, Inc.,振幅分别为29.12%、26.98%、24.57%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521522896816a49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521522896816a49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4585","BK4139","BK4539"],"gpt_icon":0},{"id":"2445776510","title":"Biomea Fusion, Inc.盘中异动 股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445776510","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445776510?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:42","pubTimestamp":1719236562,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时42分,Biomea Fusion, Inc.股票出现异动,股价大幅上涨5.51%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Revelation Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药涨幅较大,Revelation Biosciences, Inc.、Geovax Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为1007.91%、60.44%、47.75%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Geovax Labs Inc C/Wts 29/09/2025、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为68.00%、51.43%、50.87%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214242941f091f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214242941f091f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4539","BMEA"],"gpt_icon":0},{"id":"2445228454","title":"Biomea Fusion, Inc.盘中异动 下午盘股价大涨5.15%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445228454","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445228454?lang=zh_cn&edition=full","pubTime":"2024-06-21 02:11","pubTimestamp":1718907081,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日02时11分,Biomea Fusion, Inc.股票出现波动,股价大幅上涨5.15%。截至发稿,该股报5.10美元/股,成交量72.6704万股,换手率2.02%,振幅8.04%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621021122968158bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621021122968158bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4539","BMEA"],"gpt_icon":0},{"id":"2444435659","title":"Biomea Fusion, Inc.盘中异动 早盘股价大跌5.30%报4.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444435659","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444435659?lang=zh_cn&edition=full","pubTime":"2024-06-18 21:51","pubTimestamp":1718718668,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日21时51分,Biomea Fusion, Inc.股票出现异动,股价快速下跌5.30%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Nls Pharmaceutics Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Mustang Bio, Inc.、Nls Pharmaceutics Ltd.、Qualigen Therapeutics, Inc.较为活跃,换手率分别为353.89%、348.93%、294.57%,振幅较大的相关个股有Nls Pharmaceutics Ltd.、Mustang Bio, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为91.98%、52.69%、34.13%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618215108aef5792a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618215108aef5792a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BMEA","BK4139"],"gpt_icon":0},{"id":"2444761198","title":"Biomea Fusion, Inc.盘中异动 股价大跌5.39%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444761198","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444761198?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:45","pubTimestamp":1718631922,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时45分,Biomea Fusion, Inc.股票出现异动,股价快速跳水5.39%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Cns Pharmaceuticals, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为3317.20%、573.06%、93.58%,振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Sellas Life Sciences Group, Inc.,振幅分别为79.15%、31.52%、20.67%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214522aef54984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617214522aef54984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMEA","BK4539","BK4585","BK4139"],"gpt_icon":0},{"id":"2442565606","title":"Biomea Fusion, Inc.盘中异动 早盘大幅上涨5.19%报4.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442565606","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442565606?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:55","pubTimestamp":1718204100,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时55分,Biomea Fusion, Inc.股票出现波动,股价快速上涨5.19%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Avidity Biosciences, Inc.涨幅较大,Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为84.79%、32.07%、14.35%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为85.53%、60.63%、52.56%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061222550096813c18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061222550096813c18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BMEA","BK4585"],"gpt_icon":0},{"id":"2442364922","title":"BUZZ-Truist 将 Biomea Fusion 的评级下调至 \"持有\"。","url":"https://stock-news.laohu8.com/highlight/detail?id=2442364922","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442364922?lang=zh_cn&edition=full","pubTime":"2024-06-11 19:25","pubTimestamp":1718105103,"startTime":"0","endTime":"0","summary":" 6月11日 - ** Biomea Fusion股价 盘前下跌~5%至4.10美元,Truist证券将其评级从 \"买入 \"下调至 \"持有\"。** 由于肝脏毒性问题,美国FDA于6月6日对Biomea糖尿病药物的研究进行了临床搁置 。** Truist表示,由于缺乏有关这些问题的细节,很难估计解决时间表,并补充说,现金流问题使投资者保持观望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BUZZ"],"gpt_icon":0},{"id":"2442584241","title":"Biomea Fusion, Inc.盘中异动 早盘股价大跌5.07%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442584241","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442584241?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:35","pubTimestamp":1718026543,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时35分,Biomea Fusion, Inc.股票出现异动,股价急速下跌5.07%。Biomea Fusion, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Surrozen Inc C/Wts 01/08/2031 、Dermata Therapeutics Inc C/Wts 涨幅较大,Hoth Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为34.82%、32.58%、30.94%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Calidi Biotherapeutics, Inc.,振幅分别为86.12%、35.94%、23.78%。Biomea Fusion, Inc.公司简介:Biomea Fusion Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102135449681306e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102135449681306e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BMEA","BK4539"],"gpt_icon":0},{"id":"2441052156","title":"BUZZ-美国食品及药物管理局暂停糖尿病药物临床试验,Biomea 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2441052156","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441052156?lang=zh_cn&edition=full","pubTime":"2024-06-07 19:52","pubTimestamp":1717761121,"startTime":"0","endTime":"0","summary":" 6月7日 - ** 药物开发商Biomea Fusion 股价盘前暴跌60.07%,至4.50美元** 该公司周四表示,它收到了美国食品和药物管理局的通知: ,该公司正在进行的2型和1型糖尿病药物BMF-219早中期临床试验被全面搁置。** 美国 FDA 指出,该药物可能存在药物引起的肝脏毒性问题,因此存在缺陷** 券商花旗银行将预测价格从90美元下调至45美元,将2型糖尿病药物的最高销售额预期从23亿美元下调至11亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4139","BK4585","BUZZ","BK4539"],"gpt_icon":0},{"id":"2441480722","title":"BUZZ-美国 FDA 暂停糖尿病试验,Biomea 业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2441480722","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441480722?lang=zh_cn&edition=full","pubTime":"2024-06-07 04:33","pubTimestamp":1717706004,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月6日 - ** 药物开发商 Biomea Fusion 股价盘后大跌 62% 至 4.3 美元** 该公司称,美国食品及药物管理局(FDA)对其正在进行的1型和2型糖尿病实验药物早中期研究实施了全面临床搁置。 ** BMEA表示将在暂停期间继续进行安全性和疗效数据收集工作** FDA 指出在已完成的剂量递增阶段研究中观察到的可能由药物引起的肝毒性水平存在缺陷** 股价年累计下跌约22","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BMEA","BK4539","BK4585","BK4139"],"gpt_icon":0},{"id":"2441722816","title":"美国 FDA 暂停 Biomea 的糖尿病试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2441722816","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441722816?lang=zh_cn&edition=full","pubTime":"2024-06-07 04:20","pubTimestamp":1717705251,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月6日 - Biomea Fusion 周四表示,美国食品和药物管理局已对其正在进行的治疗1型和2型糖尿病的实验性药物的早中期研究实施临床搁置,导致其股价在盘中下跌55.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":0.0392},{"period":"3month","weight":-0.5355},{"period":"6month","weight":-0.6379},{"period":"1year","weight":-0.7628},{"period":"ytd","weight":-0.6529}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biomea Fusion, Inc.于2017年8月9日根据特拉华州法律注册成立。他们是一家临床前阶段的生物制药公司,致力于发现,开发和商品化不可逆小分子药物,以治疗患有遗传性癌症的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.111851},{"month":2,"riseRate":0.333333,"avgChangeRate":0.070637},{"month":3,"riseRate":0.333333,"avgChangeRate":0.321728},{"month":4,"riseRate":0,"avgChangeRate":-0.21954},{"month":5,"riseRate":0.75,"avgChangeRate":0.245778},{"month":6,"riseRate":0.25,"avgChangeRate":0.039512},{"month":7,"riseRate":0.5,"avgChangeRate":-0.034139},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.033091},{"month":9,"riseRate":0,"avgChangeRate":-0.158617},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.078427},{"month":11,"riseRate":0.666667,"avgChangeRate":0.084011},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.082267}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biomea Fusion, Inc.(BMEA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biomea Fusion, Inc.(BMEA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}